Psychedelics

The findings are particularly significant for depression and related mental health conditions, according to MindBio researchers.

The experiential training will only be available through Numinus and will utilize the protocol of MAPS

NeuroDirect Ketamine can also help alleviate headaches and migraines within minutes, with no trip involved

Ketamine is usually used as an anesthetic in human and veterinary medicine

The grant will bolster PharmAla's use of in-silico modelling

The company has a specific focus on Veteran patients

Lucy's offer of $0.85 per share represents a 142 per cent premium on Pasithea's share price

AGN Neuro plans to publish the data from the study in an upcoming issue of a peer-reviewed paper

The money will come from the state's opioid settlement funds and the research will focus on ibogaine

The deal is expected to close in the third quarter

Beckley Waves was created by the Beckley Foundation's Founder Amanda Feilding

The Natural Medicine Health act will take effect on July 1

The group aims to foster EU-funded research on psychedelics and promote drug policies based on scientific evidence

The study has been approved by the Clinical Trials Registry

The survey running until June 2 is sponsored by MAPS, Mind Medicine Australia, SABI Mind and Tiny

Research teams can receive up to $700K for an initial two-year phase to develop their studies, followed by up to $500K per year for 3 more years of research

The research will be conducted with stringent regulations and guidelines

It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies

The partnership also enables Lucy to introduce natural psilocybin products into the Canadian market

Australia will allow psychiatrists to prescribe psilocybin and MDMA for certain conditions as of July 1

Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy

The company had $126.6M less last quarter than it did in Q1 last year

Alcohol use disorder is estimated to affect some 35 million people in the United States alone

The chocolate bars will contain 1000 milligrams of psilocybin

Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others

The first clinic is set to open in the third quarter of 2023

The company has established a 3,000-square-foot facility to help cater to the growing demand for ketamine therapy

The mushroom cultivator will be supplying a private client for clinical research purposes

The study found that the extract activates specialized cells within the brain

The new school aims to provide education on psychedelic medicines to promote safe, legal and equitable access

The code was the result of a partnership between U.K.-based COMPASS Pathways and the Multidisciplinary Association for Psychedelic Studies (MAPS)

To help the new venture get started, Vitura has agreed to provide up to $2.2 million in loans

The online program 'Psychedelics: Mind, Medicine, and Culture' was announced at the Breaking Convention conference last week

The company believes the drugs have the potential to treat children and seniors

Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products

The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent

The effects from the company's MYCO-006 compounds last for only two hours and set in four times as fast

Participants in a recent study saw statistically significant improvements in their MDD symptoms

Numinus clinic network generated $4.7 million in revenue during Q2 2023, showing a significant increase of 596.9 per cent from the same period last year